Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer
Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer
Not yet recruiting · NCT07737795 · Registry updated 2026-07-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Not yet recruiting | Phase 2 | 2026-07-30 | NCT07737795 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| University of Oklahoma | 146 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| OU Health Stephenson Cancer Center | Oklahoma City | United States | 14 |